EXPIRED
Notice Number: NOT-GM-20-012
Key Dates
Release Date: January 15, 2020
First Available Due Date: April 30, 2020
Expiration Date: May 01, 2020
Issued by
National Institute of General Medical Sciences (NIGMS)
Purpose
The National Institute of General Medical Sciences (NIGMS) announces the availability of funds for Administrative Supplements to NIGMS-funded Institutional Development Award (IDeA) Networks of Biomedical Research Excellence (INBRE) (P20) awards. These funds are intended for existing INBREs to develop collaborations between investigators at the INBRE partner institutions, including primarily undergraduate institutions (PUIs), community colleges (CCs) and Tribally Controlled Colleges and Universities (TCCUs), and investigators supported by Centers of Biomedical Research Excellence (COBRE), IDeA-Infrastructure for Clinical and Translational Research (IDeA-CTR), IDeA States Pediatric Clinical Trials Network (ISPCTN) awards or Clinical and Translational Science Awards (CTSA) to institutions located in IDeA states, in research areas that are currently supported by these programs. The goal of this funding opportunity is to encourage collaborations by investigators in IDeA states while providing students a broad continuum of research opportunities. Although in-state collaboration is encouraged, the collaborative projects can also be proposed between programs across the IDeA states.
The collaborative project should be an expansion of a project currently supported by a COBRE, IDeA-CTR, ISPCTN or CTSA award. The project must not constitute a change in scope of the parent INBRE or COBRE/IDeA-CTR/ISPCTN/CTSA awards.
For these supplements, all active INBREs, including those in their final year of funding or in a no-cost extension, are eligible to apply. This applies also to COBRE, IDeA-CTR, ISPCTN or CTSA programs that will collaborate with INBREs.
Application and Submission Information
Applications by INBREs must be submitted to PA-18-591 "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin. Supp. Clinical Trial Optional)" or its subsequent reissued equivalent. by April 30, 2020.
All instructions in the SF424 (R&R) Application Guide and PA-18-591 must be followed, with the following additions:
Applicants are strongly encouraged to notify the contact listed below that a request has been submitted in response to this FOA in order to facilitate efficient processing of the request.
Inquiries
Please direct all inquiries to:
Krishan K Arora, PhD
National Institute of General Medical Sciences (NIGMS)
Email: [email protected]